27.07.2011 • NewsLonzaQ2 2011sales and profits

Strong Franc hits Lonza's Profit

Lonza reported Wednesday that its first-half profit fell 28% to 97 million Swiss francs or 1.89 francs per share from 135 million francs or 2.61 francs a year ago.

Core profit, which excluded items, dropped 23% to 107 million francs or 2.08 francs per share.

For the first half, sales fell 8.3% to 1.19 billion francs from 1.30 billion francs last year, due to strong negative currency exchange rate impacts. At constant exchange rate, revenue grew 4.8% with strong performance in Biological Custom Manufacturing and Development Services. Looking ahead, the company said it remains on track to deliver continued growth for the full year, despite ongoing market volatility combined with macro-economic uncertainties.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.